Devil's claw to suppress appetite - Ghrelin receptor modulation potential of a Harpagophytum procumbens root extract

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Torres Fuentes, Cristina ^a   Theeuwes, Wessel F ^b   McMullen, Michael K ^c,d   McMullen, Anna K ^c   Dinan, Timothy G ^a,b   Cryan, John F ^a,b   Schellekens, Harriët ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c Life Force Research   (Sweden)

^d UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN RECEPTOR; HARPAGOPHYTUM PROCUMBENS EXTRACT; CALCIUM; PLANT EXTRACT;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; CALCIUM MOBILIZATION ASSAY; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; FEEDING BEHAVIOR; FOOD INTAKE; HARPAGOPHYTUM; HORMONE RECEPTOR TRANSLOCATION; HUMAN; HUMAN CELL; INTERNALIZATION; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PLANT ROOT; TREATMENT RESPONSE; AGONISTS; ANIMAL; CALCIUM SIGNALING; CHEMISTRY; DRUG EFFECTS; HEK293 CELL LINE; METABOLISM;

ANIMALS; APPETITE; CALCIUM; CALCIUM SIGNALING; HARPAGOPHYTUM; HEK293 CELLS; HUMANS; MALE; MICE; PLANT EXTRACTS; PLANT ROOTS; RECEPTORS, GHRELIN;

EID: 84904909304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103118     Document Type: Article

References (51)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660. (Pubitemid 129516334)
2. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. (2001) A role for ghrelin in the central regulation of feeding. Nature 409: 194-198. (Pubitemid 32144284)
3. Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B (2011) Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care 14: 15-21.
4. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407: 908-913.
5. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, et al. (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974-977. (Pubitemid 26275178)
6. Schellekens H, Finger BC, Dinan TG, Cryan JF (2012) Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacol Ther 135: 316-326.
7. Yi CX, Heppner K, Tschop MH (2011) Ghrelin in eating disorders. Mol Cell Endocrinol 340: 29-34.
8. WHO (2013) Obesity and overweight. World Health Organization. 311 311.
9. Derosa G, Maffioli P (2012) Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 11: 459-471.
10. Kang JG, Park CY (2012) Anti-Obesity Drugs: A Review about Their Effects and Safety. Diabetes Metab J 36: 13-25.
11. Soares JB, Leite-Moreira AF (2008) Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 29: 1255-1270.
12. Depoortere I (2009) Targeting the ghrelin receptor to regulate food intake. Regul Pept 156: 13-23.
13. Patterson M, Bloom SR, Gardiner JV (2011) Ghrelin and appetite control in humans - potential application in the treatment of obesity. Peptides 32: 2290-2294.
14. Schellekens H, Dinan TG, Cryan JF (2010) Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 58: 2-16.
15. Costantino L (2012) Growth hormone secretagogue receptor antagonists. Expert Opinion on Therapeutic Patents 22: 697-700.
16. Yun JW (2010) Possible anti-obesity therapeutics from nature - a review. Phytochemistry 71: 1625-1641.
17. Vermaak I, Viljoen AM, Hamman JH (2011) Natural products in anti-obesity therapy. Nat Prod Rep 28: 1493-1533.
18. Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF (2014) A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review. Nutr Neurosci.
19. Stewart KM, Cole D (2005) The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: The devil's in the details. J Ethnopharmacol 100: 225-236. (Pubitemid 41206616)
20. Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N (2012) Devil's Claw-A review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J Ethnopharmacol 143: 755-771.
21. Grant L, McBean DE, Fyfe L, Warnock AM (2007) A review of the biological and potential therapeutic actions of Harpagophytum procumbens. Phytotherapy Research 21: 199-209. (Pubitemid 46479667)
22. Georgiev MI, Ivanovska N, Alipieva K, Dimitrova P, Verpoorte R (2013) Harpagoside: from Kalahari Desert to pharmacy shelf. Phytochemistry 92: 8-15.
23. AOAC (1990) Official Methods of Analysis; Helrich K, editor. Arlington, Virginia, USA.
24. International Organization for Standardization (2009) Oilseeds: Determination of Oil Content (reference Method): International Organization for Standardization.
25. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956) Colorimetric Method for Determination of Sugars and Related Substances. Anal Chem 28: 350-356.
26. Lee SC, Prosky L, Devries JW (1992) Determination of Total, Soluble, and Insoluble Dietary Fiber in Foods - Enzymatic Gravimetric Method, Mes-Tris Buffer - Collaborative Study. J AOAC Int 75: 395-416.
27. Hidalgo FJ, Alaiz M, Zamora R (2001) Determination of peptides and proteins in fats and oils. Anal Chem 73: 698-702.
28. Singleton VL, Orthofer R, Lamuela-Raventos RM (1999) Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Oxidants and Antioxidants, Pt A 299: 152-178. (Pubitemid 28483890)
29. Torres-Fuentes C, Alaiz M, Vioque J (2011) Affinity purification and characterisation of chelating peptides from chickpea protein hydrolysates. Food Chemistry 129: 485-490.
30. Schellekens H, McNamara O, Dinan TG, McCarthy JV, McGlacken GP, et al. (2013) Semagacestat, a gamma-secretase inhibitor, activates the growth hormone secretagogue (GHS-R1a) receptor. J Pharm Pharmacol 65: 528-538.
31. Schellekens H, van Oeffelen WEPA, Dinan TG, Cryan JF (2013) Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) Attenuates Ghrelin-mediated Signaling. Journal of Biological Chemistry 288: 181-191.
32. Schellekens H, McNamara O, Dinan TG, McCarthy JV, McGlacken GP, et al. (2012) Semagacestat, a γ-secretase inhibitor, activates the growth hormone secretagogue (GHS-R1a) receptor. Journal of Pharmacy and Pharmacology: n/a-n/a.
33. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, et al. (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345. (Pubitemid 32149296)
34. Finger BC, Schellekens H, Dinan TG, Cryan JF (2011) Is there altered sensitivity to ghrelin-receptor ligands in leptin-deficient mice?: importance of satiety state and time of day. Psychopharmacology (Berl) 216: 421-429.
35. Qi J, Chen JJ, Cheng ZH, Zhou JH, Yu BY, et al. (2006) Iridoid glycosides from Harpagophytum procumbens DC (devil's claw). Phytochemistry 67: 1372-1377. (Pubitemid 44080273)
36. O'Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. European Journal of Biochemistry 267: 5421-5426.
37. Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW (2003) High constitutive signaling of the ghrelin receptor - identification of a potent inverse agonist. Mol Endocrinol 17: 2201-2210. (Pubitemid 37352532)
38. Els S, Beck-Sickinger AG, Chollet C (2010) Ghrelin receptor: high constitutive activity and methods for developing inverse agonists. Methods Enzymol 485: 103-121.
39. Liu G, Fortin JP, Beinborn M, Kopin AS (2007) Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities. J Pharmacol Exp Ther 322: 1036-1043. (Pubitemid 47295807)
40. Camina JP, Carreira MC, El Messari S, Llorens-Cortes C, Smith RG, et al. (2004) Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 145: 930-940 . (Pubitemid 38183837)
41. Ritter SL, Hall RA (2009) Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol 10: 819-830.
42. Beck B, Richy S, Stricker-Krongrad A (2004) Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats. Life Sci 76: 473-478. (Pubitemid 39458314)
43. Brendler T, Gruenwald J, Ulbricht C, Basch E (2006) Devil's Claw (Harpagophytum procumbens DC): an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother 6: 89-126. (Pubitemid 351146702)
44. Ferguson SS (2007) Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol Sci 28: 173-179.
45. Moore CA, Milano SK, Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69: 451-482. (Pubitemid 46457651)
46. Lefkowitz RJ (1998) G protein-coupled receptors III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. Journal of Biological Chemistry 273: 18677-18680.
47. Mear Y, Enjalbert A, Thirion S (2013) GHS-R1a constitutive activity and its physiological relevance. Front Neurosci 7: 87.
48. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular Mechanism of beta-Arrestin-Biased Agonism at Seven-Transmembrane Receptors. Annual Review of Pharmacology and Toxicology, Vol 52 52: 179-197.
49. Petersen PS, Woldbye DP, Madsen AN, Egerod KL, Jin C, et al. (2009) In vivo characterization of high Basal signaling from the ghrelin receptor. Endocrinology 150: 4920-4930.
50. Günther M, Laufer S, Schmidt PC (2006) High anti-inflammatory activity of harpagoside-enriched extracts obtained from solvent-modified super- and subcritical carbon dioxide extractions of the roots of Harpagophytum procumbens. Phytochemical Analysis 17: 1-7. (Pubitemid 43141391)
51. Howarth NC, Saltzman E, Roberts SB (2001) Dietary fiber and weight regulation. Nutr Rev 59: 129-139. (Pubitemid 32494625)